HIGHBRIDGE CAPITAL MANAGEMENT LLC 13D and 13G filings for CERo Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-25 07:24 am Sale |
2022-12-31 | 13G | CERo Therapeutics Holdings, Inc. CERO |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0.000% |
-10,378 (Position Closed) |
Filing |
| 2022-02-03 08:21 am Purchase |
2021-12-31 | 13G | CERo Therapeutics Holdings, Inc. CERO |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 10,378 5.640% |
10,378 (New Position) |
Filing |